“…From there on, reports of strains of S. aureus (predominately MRSA) demonstrating the heterogeneous VISA (hVISA) or VISA phenotype have now been reported for many countries including the United States, Japan, Australia, France, Scotland, Brazil, South Korea, Hong Kong, South Africa, Thailand, Israel, and others (Bierbaum et al 1999;Chang et al, 2003;Denis et al 2002;Ferraz et al, 2000Gemmell, 2004Howden et al, 2010;Kim et al, 2000;Perichon & Courvalin, 2006;Sng et al,2005;Song et al, 2004;Tenover et al, 2004;Weigel et al, 2007) Nowadays it is conceivable that VISA phenotype is related to the bacterial cell wall thickening, a passive resistance mechanism that reduces vancomycin access to its active site, which is localized in the cytoplasmic membrane in the division septum (Howden et al, 2010). It results in accumulation of acyl-D-alanyl-D-alanine (X-DAla-D-Ala) targets in the periphery that sequester glycopeptides (Cui et al, 2003).…”